GRCE Grace Therapeutics, Inc.
Grace Therapeutics, Inc. (GRCE) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: November 5, 2026 , by Opaleye Management Inc. .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner | Buy | 3,087 | $1.77 | $5.5K | 3,054,853 | |
| Opaleye Management Inc. | 10% Owner | Buy | 5,027 | $1.80 | $9.1K | 3,051,766 | |
| Opaleye Management Inc. | 10% Owner | Buy | 10,328 | $1.79 | $18.5K | 3,046,739 | |
| Opaleye Management Inc. | 10% Owner | Buy | 66,411 | $1.77 | $117.4K | 3,036,411 | |
| Opaleye Management Inc. | 10% Owner | Buy | 21,390 | $1.93 | $41.2K | 2,970,000 | |
| Opaleye Management Inc. | 10% Owner | Buy | 4,256 | $1.88 | $8.0K | 2,948,610 | |
| Opaleye Management Inc. | 10% Owner | Buy | 36,347 | $1.89 | $68.8K | 2,944,354 | |
| Opaleye Management Inc. | 10% Owner | Buy | 23,485 | $1.95 | $45.7K | 2,908,007 | |
| Opaleye Management Inc. | 10% Owner | Buy | 11,233 | $1.93 | $21.7K | 2,884,522 | |
| Opaleye Management Inc. | 10% Owner | Buy | 7,215 | $2.02 | $14.6K | 2,873,289 | |
| Opaleye Management Inc. | 10% Owner | Buy | 5,340 | $2.04 | $10.9K | 2,866,074 | |
| Opaleye Management Inc. | 10% Owner | Buy | 2,077 | $2.02 | $4.2K | 2,860,734 | |
| Opaleye Management Inc. | 10% Owner | Buy | 1,694 | $2.06 | $3.5K | 2,858,657 | |
| Opaleye Management Inc. | 10% Owner | Buy | 20,000 | $2.07 | $41.4K | 2,856,963 | |
| Opaleye Management Inc. | 10% Owner | Buy | 38,796 | $2.04 | $79.0K | 2,836,963 | |
| Opaleye Management Inc. | 10% Owner | Buy | 5,318 | $2.10 | $11.2K | 2,790,318 | |
| Opaleye Management Inc. | 10% Owner | Buy | 9,771 | $2.10 | $20.5K | 2,785,000 | |
| Kohli Prashant | Chief Executive Officer | Buy | 100,000 | $2.14 | $214.0K | 121,357 | |
| Opaleye Management Inc. | 10% Owner | Buy | 5,836 | $2.09 | $12.2K | 2,775,229 | |
| Opaleye Management Inc. | 10% Owner | Buy | 9,393 | $2.10 | $19.7K | 2,769,393 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.